Expo

May 22, 2024

BIO International Convention

BIO International Convention 3-6 june 2024 | San Diego. Meet us at Italian Pavilion at booth #3623(Anemocyte table, H).

https://anemocyte.com/wp-content/uploads/2024/05/AMC_News_Bio-International-Convention-2024@2x-1536x1152-1.jpg 1536 1152 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/05/AMC_News_Bio-International-Convention-2024@2x-1536x1152-1.jpg May 22, 2024 April 23, 2025

ICH Q14 analytical development guideline

May 15, 2024

Leveraging ICH Q14 for Analytical Development

What’s new with the ICH Q14 for Analytical development?To regulate drug production, there are a multitude of documents that pharmaceutical companies can refer

https://anemocyte.com/wp-content/uploads/2024/04/AMC_News_ICHQ14-1.jpg 1200 900 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/04/AMC_News_ICHQ14-1.jpg May 15, 2024 March 4, 2025

May 15, 2024

ISCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ISCT 2024 in Vancouver

https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_ISCT-2024-–-3@2x.jpg 2400 1800 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_ISCT-2024-–-3@2x.jpg May 15, 2024 April 23, 2025

April 23, 2024

ASGCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ASGCT Annual Meeting 2024 in Baltimore

https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_ASGCT-2024@2x.jpg 2400 1800 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_ASGCT-2024@2x.jpg April 23, 2024 April 23, 2025

April 4, 2024

CPHI Japan

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to CPHI Japan 2024

https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_CPHI-Japan-2024@2x.jpg 2400 1800 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_CPHI-Japan-2024@2x.jpg April 4, 2024 February 26, 2025

March 25, 2024

Cell & Gene

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Cell & Gene Meeting 2024 in Rome

https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_Cell-Gene-2024@2x.jpg 2400 1800 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_Cell-Gene-2024@2x.jpg March 25, 2024 February 26, 2025

March 6, 2024

Advanced Therapies

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Advanced Therapies 2024 in London

https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_Advanced-therapies-2024@2x.jpg 2400 1800 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_Advanced-therapies-2024@2x.jpg March 6, 2024 February 26, 2025

March 5, 2024

RNA Leaders Europe

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to RNA Leaders Europe Congress 2024 in Basel, Switzerland.

https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_RNA-Leaders-2024@2x.jpg 2400 1800 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_RNA-Leaders-2024@2x.jpg March 5, 2024 April 23, 2025

January 17, 2024

mRNA-Based Therapeutics Summit

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to mRNA Based Therapeutics Summint 2024 in Berlin.

https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_MRNA-2023@2x.jpg 2400 1800 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_MRNA-2023@2x.jpg January 17, 2024 February 26, 2025

October 4, 2023

ESGCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to European Society of Gene & Cell Therapy 2023 in Brussels

https://anemocyte.com/wp-content/uploads/2023/10/AMC_2023-ESG.jpg 1200 900 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2023/10/AMC_2023-ESG.jpg October 4, 2023 April 23, 2025

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961

Privacy & cookie Policy